Document:

EXECUTION VERSION

 

Share Purchase

Agreement

 

between

 

Akers Biosciences,
Inc.

as Seller

 

and

 

Chubeworkx
Guernsey Limited

as Purchaser

 

relating to

 

the sale and
purchase of 20 ordinary shares of (EN)10

(Guernsey) Limited

 

 

Simmons & Simmons LLP CityPoint One
Ropemaker Street London EC2Y 9SS United Kingdom

T +44 20 7628 2020 F +44 20 7628 2070 DX
Box No 12

  

    	1

    	 

    

 

THIS
AGREEMENT is dated the 12th of  June 2013 and made

 

BETWEEN

 

		(1)	AKERS BIOSCIENCES, INC. a company incorporated in the state of New Jersey, United States
of America and whose registered office is at 201 Grove Road, Thorofare, New Jersey 08086, United States of America (the “Seller”);
and

 

		(2)	CHUBEWORKX GUERNSEY LIMITED a company registered in Guernsey with registered number 55801
and whose registered office is at 18-20 Le Pollet, St Peter Port, Guernsey, GY1 1WH, Channel Islands (the “Purchaser”).

 

RECITALS:

 

		(A)	The Seller is the beneficial owner of 20 ordinary shares of £1 each in the share capital
of the Company (as defined below) (the “Sale Shares”).

 

		(B)	The remaining shares in the Company are owned by other members of the Purchaser’s Group.

 

		(C)	The Purchaser has agreed to buy and the Seller has agreed to sell the Sale Shares on and subject
to the terms of this Agreement.

 

		(D)	The Purchaser and the Seller will enter into the Subscription Agreement (as defined below) on or
about the date of this Agreement and the acquisition of the Sale Shares is conditional on the closing of the Subscription Agreement.

 

THE PARTIES AGREE that:

 

		1.	Interpretation

 

		1.1	In this Agreement where the context admits:

 

“Agreed
Form” means, in relation to any document, a document in the terms signed or initialled by or on behalf of the parties
for identification.

 

“Affiliate”
means, in relation to a body corporate, any subsidiary undertaking or parent undertaking of such body corporate, and any subsidiary
undertaking of any such parent undertaking for the time being.

 

“AIM” means
the market of that name operated by the London Stock Exchange plc.

 

“AIM Rules”
means the rules for AIM companies and their nominated advisers issued by the London Stock Exchange plc in relation to AIM traded
securities.

 

“Authority”
means any competent governmental, administrative, supervisory, regulatory, judicial, determinative, disciplinary, enforcement or
tax raising body, authority, agency, board, department, court or tribunal of any jurisdiction and whether supranational, national,
regional or local.

 

“Business
Day” means a day (other than a Saturday or Sunday) on which banks are open for ordinary face to face banking business
in London.

 

“Common
Stock” means the 80,000,000 shares of common stock of US$0.001 each in the Seller to be subscribed for by, and delivered
to, the Purchaser pursuant to the Subscription Agreement.

 

    	2

    	 

    

 

“Company”
means (EN)10 (Guernsey) Limited, a company registered in Guernsey with registered number 52822 and whose registered office is at
18-20 Le Pollet, St Peter Port, Guernsey, GY1 1WH, Channel Islands.

 

“Completion”
means completion of the sale and purchase of the Sale Shares in accordance with Clause 5.

 

“Condition”
means the condition set out in Clause 4.

 

“Consideration”
means the sum of US$100,000.

 

“Encumbrance”
means any interest or equity of any person (including any right to acquire, option or right of pre-emption), any mortgage, charge,
pledge, lien, assignment, hypothecation, security interest (including any created by law), or other security agreement or arrangement.

 

“Excluded
Shares” means the entire issued share capital of the Company other than the Sale Shares.

 

“Purchaser’s
Group” means the Purchaser and each of its Affiliates, including the Company.

 

“Sale
Shares” has the meaning given to it in Recital A.

 

“Seller’s
Group” means the Seller and each of its Affiliates, other than the Company. 

 

“Subscription
Agreement” means the agreement between the Purchaser and Seller dated on or about the date of this Agreement, pursuant
to which the Purchaser will purchase and subscribe for the Common Stock for an aggregate subscription price of US$1,600,000.

 

		1.2	Construction of certain references

 

In
this Agreement, where the context admits:

 

		(A)	words and phrases the definitions of which are contained or referred
to in Part 38 Companies Act 2006 shall be construed as having the meanings thereby attributed to them;

 

		(B)	references to clauses
are references to clauses of this Agreement;

 

		(C)	references to the singular shall include the plural and vice
versa and references to the masculine, the feminine and the neuter shall include all such genders;

 

		(D)	"person" includes any individual, partnership,
body corporate, corporation sole or aggregate, state or agency of a state, and any unincorporated association or organisation,
in each case whether or not having separate legal personality; and

 

		(E)	"company" includes any corporate body.

 

		2.	Sale of Sale Shares

 

Subject to the terms of this
Agreement, the Seller shall sell with full title guarantee and the Purchaser shall purchase the Sale Shares, free from all Encumbrances
and together with all rights attaching to the Sale Shares on or after the date of this Agreement.

 

    	3

    	 

    

 

		3.	Consideration

 

The total consideration for
the Sale Shares shall be US$100,000, payable in cash on Completion to such account as the Seller shall specify in writing to the
Purchaser.

 

		4.	Conditions

 

		4.1	Condition

 

Completion is conditional upon
the delivery of the Common Stock to the Purchaser and the admission to trading on AIM of the Common Stock in accordance with the
Subscription Agreement.

 

		4.2	Failure to satisfy the Condition

 

In the event that the Condition
shall not have been satisfied or waived by the Purchaser on or before 30 June 2013, this Agreement shall lapse and no party shall
make any claim against any other in respect hereof, save for any antecedent breach.

 

		4.3	Waiver

 

The Purchaser may waive in
whole or in part the Condition or extend the period in which the Condition is to be satisfied.

 

		5.	Completion

 

		5.1	Date of Completion

 

Completion shall take place
immediately following the satisfaction of the Condition.

 

		5.2	Seller’s Obligations

 

At Completion
the Seller shall deliver to the Purchaser:

 

		(A)	duly executed transfers of the Sale Shares by the registered holders thereof in favour of the Purchaser
or its nominees together with the relevant share certificates in respect of each of the Sale Shares; and

 

		(B)	a stock transfer form in Agreed Form.

 

		5.3	Purchaser’s Obligations

 

At Completion the Purchaser
shall pay the Consideration to the Seller by payment into the Seller’s bank account.

 

		5.4	Failure to Complete

 

If in any respect the obligations
of the Seller or the Purchaser are not complied with on the date for Completion, as provided in clause 5.1 above, the party not
in default may:

 

		(A)	defer Completion to a date not more than 28 days after the date set by clause 5.1 (and so that
the provisions of this clause 5.4, apart from this clause 5.4(A), shall apply to Completion as so deferred); or

 

    	4

    	 

    

 

		(B)	proceed to Completion so far as practicable (without prejudice to its rights under this Agreement);
or

 

		(C)	rescind this Agreement.

 

		6.	Warranties

 

		6.1	The Seller warrants that each of the following statements is
true, accurate and not misleading on the date of this agreement and as at the date of Completion:

 

		(A)	Capacity

 

The Seller has the requisite
power and authority to enter into and perform this Agreement, and may enter into this Agreement and perform its obligations under
this Agreement without requiring or obtaining the consent of its shareholders or of any other person, Authority or body.

 

		(B)	Enforceability

 

		(1)	This Agreement when executed by the Seller constitutes valid, binding and enforceable obligations
of the Seller in accordance with its terms (without prejudice to creditor protection laws of general application).

 

		(2)	The execution, delivery and performance of, and compliance with the terms of, this Agreement will
not result in a conflict, breach or default which is material in the context of the transaction the subject of this Agreement,
with, of or under:

 

		(a)	any instrument to which the Seller is a party or by which it is bound; or

 

		(b)	any order, judgment or decree, or undertaking given to any Authority or person, which applies to
or by which the Seller or any of its property is bound.

 

		(C)	Ownership of Sale Shares

 

		(1)	The Seller is the registered and sole beneficial owner of the Sale Shares and has the right to
transfer entire legal and beneficial title to the Sale Shares free from any Encumbrances in accordance with the terms of this Agreement.

 

		(2)	The Seller does not own or have any other rights in relation to the Excluded Shares.

 

		(3)	There is no dispute concerning the Seller’s title to the Sale Shares or its ability to sell
the same and no other person has claimed to have title to, or to be entitled to, any interest in the Sale Shares.

 

		(4)	The Seller is not engaged in any litigation, arbitration or other proceedings in any way relating
to its title to the Sale Shares, and the Company has not received any application for the rectification of its register of members.
There are no circumstances likely to give rise to any of the matters referred to in this paragraph.

 

    	5

    	 

    

 

		7.	Waiver of Claims

 

The Seller undertakes to and
for the benefit of the Purchaser that it will not make or pursue any claim or action howsoever arising against the Company or any
of the Company's employees in respect of any loss or liability the Seller may incur pursuant to this Agreement (or any other document
referred to in this Agreement) or otherwise in connection with the sale of the Sale Shares to the Purchaser.

 

		8.	Confidentiality

 

		8.1	Confidentiality

 

Subject
to clauses 8.2, 8.3 and 8.4, each party:-

 

		(A)	shall treat as strictly confidential the provisions of this Agreement and the process of their
negotiation and all information about the other party obtained or received by it as a result of negotiating, entering into or performing
its obligations under this Agreement ("Confidential Information"); and

 

		(B)	shall not, except with the prior written consent of the other party (which shall not be unreasonably
withheld or delayed), make use of (save for the purposes of performing its obligations under this Agreement) or disclose to any
person any Confidential Information.

 

		8.2	Permitted disclosure or use

 

		(A)	Clause 8.1 shall not apply if and to the extent that the party using or disclosing Confidential
Information can demonstrate that:

 

		(1)	such disclosure is required by law or the AIM Rules, or is required
or requested by any supervisory, regulatory or governmental body having jurisdiction over it and whether or not the requirement
or request has the force of law; or

 

		(2)	such disclosure is to its professional advisers in relation to
the negotiation entry into or performance of this Agreement or any matter arising out of the same;

 

		(3)	in the case of disclosure or use, the Confidential Information
concerned was lawfully in its possession (as evidenced by written records) prior to its being obtained or received as described
in clause 8.1(A); or

 

		(4)	in the case of disclosure or use, the Confidential Information
concerned has come into the public domain other than through its fault or the fault of any person to whom such Confidential Information
has been disclosed in accordance with clause 8.1(B).

 

		(B)	Nothing in this clause 8 prevents any Confidential Information being disclosed:

 

		(1)	by the Seller or by any relevant member of the Seller’s Group to its professional advisers,
auditors, bankers or a bona fide potential purchaser of any member of the Seller’s Group (by way of a direct or indirect
sale of the shares or assets of the relevant member of the Seller’s Group) but, before any disclosure to any such person,
the Seller shall procure that such person is made aware of the terms of this clause and shall use its best endeavours to procure
that such person enters into an appropriate undertaking to maintain the confidentiality of all Confidential Information;

 

    	6

    	 

    

 

		(2)	by the Purchaser or by any relevant member of the Purchaser's Group to its professional advisers,
auditors, bankers or a bona fide potential purchaser of any member of the Purchaser's Group (by way of a direct or indirect sale
of the shares or assets of the relevant member of the Purchaser's Group) but, before any disclosure to any such person, the Purchaser
shall procure that such person is made aware of the terms of this clause and shall use its best endeavours to procure that such
person enters into an appropriate undertaking to maintain the confidentiality of all Confidential Information; or

 

		(3)	to a member of the Seller’s Group or a member of the Purchaser's Group or any of their respective
officers, directors, employees or consultants who need to know the Confidential Information for the purposes of their duties.

 

		8.3	Continuance of restrictions

 

The restrictions contained
in this clause 8 shall survive Completion and shall continue without limit of time.

 

		8.4	Privilege

 

Where any Confidential Information
is also privileged, the waiver of such privilege is limited to the purposes of this Agreement and does not, and is not intended
to, result in any wider waiver of the privilege. Any party hereto in possession of any Confidential Information relating to any
other party hereto shall take all reasonable steps to protect the privilege of that party therein and shall inform that party if
any step is taken by any other person to obtain any of its privileged Confidential Information.

 

		9.	Announcements

 

		9.1	Restrictions

 

Subject to clause 9.2 and whether
or not any restriction contained in clause 8 applies, no party to this Agreement shall make any announcement, (including, without
limitation any communication to the public, to any customers or suppliers of the Company, or to all or any of the employees of
the Company) concerning the provisions or subject matter of this Agreement or containing any information about the other party
without the prior written approval of the other (which shall not be unreasonably withheld or delayed).

 

		9.2	Permitted announcements

 

Clause 9.1 shall not apply
if and to the extent that such announcement is required by law or the AIM Rules, or by any supervisory, regulatory or governmental
body having jurisdiction over it and whether or not the requirement has the force of law and provided that any such announcement
shall be made only after consultation with the other party.

 

    	7

    	 

    

 

		9.3	Continuance of restrictions

 

The restrictions contained
in this clause 9 shall survive Completion and shall continue without limit of time.

 

		10.	Provisions relating to this Agreement

 

		10.1	Successors and assigns

 

This Agreement shall be binding
upon and enure for the benefit of the successors of the parties but shall not be assignable by any party without the prior written
consent of the other party.

 

		10.2	Whole agreement and variations

 

		(A)	This Agreement constitutes the whole agreement between the parties relating to its subject matter
and supersedes and extinguishes any prior drafts, agreements and undertakings, whether in writing or oral, relating to such subject
matter.

 

		(B)	No variation of this Agreement shall be effective unless made in writing and signed by each of
the parties.

 

		10.3	Agreement survives Completion

 

The warranties set out in clause
6 and all other provisions of this Agreement, in so far as the same shall not have been performed at Completion, shall remain in
full force and effect notwithstanding Completion.

 

		10.4	Rights etc cumulative and other matters

 

		(A)	The rights, powers, privileges and remedies provided in this Agreement are cumulative and are not
exclusive of any rights, powers, privileges or remedies provided by law or otherwise.

 

		(B)	No failure to exercise nor any delay in exercising any right, power, privilege or remedy under
this Agreement shall in any way impair or affect the exercise thereof or operate as a waiver thereof in whole or in part.

 

		(C)	No single or partial exercise of any right, power, privilege or remedy under this Agreement shall
prevent any further or other exercise thereof or the exercise of any other right, power, privilege or remedy.

 

		10.5	Invalidity

 

If any provision of this Agreement
shall be held to be illegal, void, invalid or unenforceable under the laws of any jurisdiction, the legality, validity and enforceability
of the remainder of this Agreement in that jurisdiction shall not be affected, and the legality, validity and enforceability of
the whole of this Agreement in any other jurisdiction shall not be affected.

 

		10.6	Counterparts

 

This Agreement may be executed
in any number of counterparts, which shall together constitute one Agreement. Any party may enter into this Agreement by signing
any such counterpart.

 

    	8

    	 

    

 

		10.7	Costs

 

Save as otherwise expressly
provided herein, each party shall bear its own costs arising out of or in connection with the preparation, negotiation and implementation
of this Agreement.

 

		10.8	Notices

 

		(A)	Any notice or other communication required to be given under this Agreement or in connection with
the matters contemplated by it shall, except where otherwise specifically provided, be in writing in the English language and shall
be addressed as provided in clause 10.8(B) and may be:

 

		(1)	personally delivered, in which case it shall be deemed to have
been given upon delivery at the relevant address; or

 

		(2)	sent by pre-paid first class post or, if available, airmail or
by air courier, in which case it shall be deemed to have been given two Business Days after the date of posting or delivery to
the courier; or

 

		(3)	sent by fax, in which case it shall be deemed to have been given
when despatched, subject to confirmation of uninterrupted transmission by a transmission report provided that any notice despatched
by fax after 17.00 hours (at the place where such fax is to be received) on any day shall be deemed to have been received at 08.00
on the next Business Day; or

 

		(4)	sent by electronic mail, in which case it shall be given at the
time it left the e-mail gateway of the server of the notice, but subject to the same provisions concerning receipt after 17.00
hours which apply to notices sent by fax.

 

		(B)	The addresses and other details of the parties referred to in clause 10.8(B) are, subject to clause
10.8(C)(1):

 

	Name:	Akers Biosciences, Inc.
	For the attention of:	Thomas A Nicolette
	Address:	201 Grove Road
	 	Thorofare, New Jersey 08086
	 	United States of America
	 	 
	Fax number:	+1 856 848 0269
	E-mail address	tan@akersbiosciences.com
	 	 
	Name:	Chubeworkx Guernsey Limited
	For the attention of:	Mark Chasey
	Address:	18-20 Le Pollet
	 	St Peter Port
	 	Guernsey GY1 1WH
	 	 
	Fax number:	+44 1481 722 584
	E-mail address	mchasey@oaktrust.co.uk

 

    	9

    	 

    

 

	With a copy to:	 
	 	 
	Name:	Chubeworkx Guernsey Limited
	For the attention of:	Darren Jenkins
	Address:	37 Ixworth Place
	 	London SW3 3QH
	 	UNITED KINGDOM
	 	 
	Fax number:	+44 20 7225 6425
	E-mail address	darren.jenkins@chubeworkx.com

 

		(C)	In proving service of any notice it shall be sufficient to prove:

 

		(1)	in the case of a notice sent by post that such notice was properly addressed, stamped and placed
in the post;

 

		(2)	in the case of a notice personally delivered that it was delivered to or left at the specified
address;

 

		(3)	in the case of a notice sent by fax that it was duly despatched to the specified number as confirmed
by a transmission report;

 

		(4)	in the case of a notice sent by e-mail that the e-mail left the e-mail gateway of the server of
the notice; and

 

		(5)	in the case of a notice sent by air courier that it was delivered to a representative of the courier.

 

		(D)	Any party to this Agreement may notify the other party of any change to its address or other details
specified in clause 10.8(B), provided that such notification shall only be effective on the date specified in such notice or five
Business Days after the notice is given, whichever is later.

 

		10.9	Further Assurance

 

At any time after the date
of this Agreement the parties will, and will use all reasonable endeavours to procure that any necessary person will, at the cost
of the relevant party, execute such documents and do such acts and things as that party may reasonably require for the purpose
of giving to that party the full benefit of all the provisions of this Agreement.

 

    	10

    	 

    

 

		11.	Law and Jurisdiction

 

		11.1	English Law

 

This Agreement and any non-contractual
obligations arising from or in connection with it shall be governed by, and construed in accordance with, English law.

 

		11.2	Jurisdiction

 

In relation to any legal action
or proceedings to enforce this Agreement or arising out of or in connection with this Agreement ("Proceedings")
each of the parties irrevocably submits to the exclusive jurisdiction of the English courts and waives any objection to Proceedings
in such courts on the grounds of venue or on the grounds that the Proceedings have been brought in an inappropriate forum.

 

		11.3	Contracts (Rights of Third Parties) Act 1999

 

Except in relation to clause
7, no person who is not a party to this Agreement shall have any right under the Contracts (Rights of Third Parties) Act 1999 to
enforce any term of this Agreement.

 

    	11

    	 

    

 

IN WITNESS of which this Agreement
has been entered into by the parties on the date first above written.

 

	SIGNED by 	 	    )
	duly authorised for and	    )
	on behalf of AKERS	    )
	BIOSCIENCES, INC.	    )
	 	 	 
	SIGNED by 	 	    )
	duly authorised for and	    )
	on behalf of CHUBEWORKX	    )
	GUERNSEY LIMITED	    )

 

    	12VOTING AGREEMENT

 

THIS VOTING AGREEMENT
(this “Agreement”), made as of the 12th day of June, 2013, is by and among AKERS BIOSCIENCES, INC., a corporation
incorporated under the laws of the State of New Jersey and located at 201 Grove Road, Thorofare, New Jersey 08086 USA
(the “Company”), THOMAS J. KNOX, an individual residing at 50 South 16th Street, Suite 4604, Philadelphia,
Pennsylvania 19102 (“Knox” or the “Key Shareholder”) and CHUBEWORKX GUERNSEY LIMITED, a company incorporated
in Guernsey with registration number 55801 with its registered office at 18-20 Le Pollet, St Peter Port, Guernsey, GY1 1WH, Channel
Islands (the “Investor”). The Company, Knox and the Investor are sometimes collectively referred to herein as the “Parties”
and individually referred to herein as a “Party.”

 

WITNESSETH:

 

WHEREAS, the
Company and the Investor are parties to a Subscription Agreement of even date herewith (the “Subscription Agreement”),
pursuant to which the Company has agreed to sell and the Investor has agreed to purchase 80,000,000 shares of Common Stock of the
Company (the “Investor Shares”);

 

WHEREAS, the
obligations of the Investor in the Subscription Agreement are conditioned upon the execution and delivery of this Agreement by
Knox and the Company; and

 

WHEREAS,
in order to induce the Investor to enter into the Subscription Agreement and invest funds in the Company pursuant thereto, the
Parties desire to enter into this Agreement to set forth their agreements and understandings with respect to how shares of the
Company’s capital stock held by them will be voted and to set forth certain other agreements between the Parties.

 

NOW, THEREFORE,
in consideration of the foregoing, and for other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the Parties agree as follows:

 

1.          Agreement
to Vote. The Key Shareholder and the Investor, as holders of Preferred Stock or Common Stock of the Company, each hereby agrees
on behalf of itself and any transferee or assignee of any such shares of such Common Stock or Preferred Stock constituting a Related
Party (as such term is defined below in this Section 1), to hold all of such shares of Common Stock and Preferred Stock and any
other securities of the Company acquired by the Key Shareholder or the Investor in the future, including without limitation any
shares of Common Stock or Preferred Stock of the Company acquired by the Key Shareholder or the Investor pursuant to any stock
option, warrant or any other instrument (and any securities of the Company issued with respect to, upon conversion of, or in exchange
or substitution for such Preferred Stock, Common Stock or other securities) (the “Shares”) subject to, and to vote
the Shares at a regular or special meeting of stockholders (or by written consent) in accordance with, the provisions of this Agreement.
For purposes of this Agreement, a “Related Party” shall mean (a) any present or former known spouse, ancestor
or descendant of the Key Shareholder or any trust or other similar entity for the benefit of any of the foregoing persons, (b)
any person or entity directly or indirectly controlled by the Key Shareholder or the Investor or (c) any person or entity directly
or indirectly controlling, controlled by or under common control with, the Company. For the purposes of this definition, “control”
(including, with correlative meaning, the terms “controlling,” “controlled by” and “under common
control with”) shall mean the possession, directly or indirectly, of the power to direct or cause the direction of management
and policies of an entity, whether through the ownership of voting securities, by contract or otherwise.

 

    	 

    	 

    

 

2.          Company
Independence. The Key Shareholder and the Investor each separately undertake that they will take all necessary actions to ensure
that the Company maintains independence with each of the Key Shareholder and its Related Parties (in the case of the Key
Shareholder) and the Investor and its Related Parties (in the case of the Investor), in connection with
all of the Company’s business operations and the AIM Rules (in particular AIM Rule 13).

 

3.          Board
Size. The Key Shareholder shall vote at a regular or special meeting of stockholders (or by written consent) such Shares that
the Key Shareholder owns (or as to which the Key Shareholder has voting power), and the Company and the Key Shareholder shall take
all other actions necessary to ensure that at all times, (a) the size of the Board shall be a maximum of five (5) directors and
(b) the Company’s organizational documents specify that each director has equal rights to each other director, including
without limitation voting in favor of any amendment to the Certificate of Incorporation or Bylaws of the Company that may be necessary
under applicable law in order to legally and effectively implement all of the requirements under this Section 3. The Company and
the Key Shareholder further agree to take any and all other actions that may be necessary under applicable law in order to implement
the requirements of this Section 3, including without limitation calling any special meetings of the shareholders and/or Board
of Directors and/or entering into written consents of the shareholders and/or Board of Directors as necessary in order to effectively
implement the requirements of this Section 3. The Company and the Key Shareholder warrant and agree that the requirements set forth
above in this Section 3 shall be implemented as soon as reasonably and practically possible following the Company’s next
annual general shareholders’ meeting which is currently anticipated to be held in July 2013 (“AGM”), provided,
however, that the requirements set forth above in this Section 3 shall be implemented by no later than thirty (30) calendar days
following such AGM.

 

4.          Election
and Removal of Directors. On all matters relating to the election of one or more directors of the Company, each of the
Key Shareholder and the Investor shall vote at regular or special meetings of shareholders and give written consent with respect
to, such number of Shares then owned by them (or as to which they then have voting power) as may be necessary to elect the following
individuals to the Board:

 

(a)          at
each election of directors in which the holders of any series of Preferred Stock of the Company (“Preferred Stock”),
voting as a separate class, are entitled to elect directors of the Company, for so long as the Investor continues to hold shares
of Common Stock of the Company entitling the Investor to ten percent (10%) or more of the voting rights with respect to the Company,
the Key Shareholder shall vote all of its Shares comprised of Preferred Stock so as to elect one (1) individual designated by the
Investor, subject only to approval of the designated individual by the AIM market of the London Stock Exchange plc (“AIM”);

 

    	2

    	 

    

 

(b)          at
each election of directors in which the holders of Common Stock, voting as a separate class, are entitled to elect directors of
the Company, for so long as the Investor continues to hold shares of Common Stock of the Company entitling
the Investor to ten percent (10%) or more of the voting rights with respect to the Company, the Key Shareholder shall vote
all of its Shares comprised of Common Stock so as to elect one (1) individual designated by the Investor,
subject only to approval of the designated individual by AIM;

 

(c)          at
each election of directors in which the holders of Common Stock, voting as a separate class, are entitled to elect directors of
the Company, for so long as a Key Shareholder continues to hold shares of Common Stock and/or Preferred
Stock of the Company entitling such Key Shareholder to ten percent (10%) or more of the voting rights with respect to the Company,
the Investor shall vote all of its Shares comprised of Common Stock so as to elect one (1) individual
designated by such Key Shareholder, subject only to approval of the designated individual by AIM; 

 

(d)          at
each election of directors in which the holders of Common Stock and holders of Preferred Stock, voting together as a single class
on an as-converted basis, are entitled to elect directors of the Company, for so long as the Investor
continues to hold shares of Common Stock of the Company entitling the Investor to ten percent (10%) or more of the voting rights
with respect to the Company, the Key Shareholder shall vote all of its Shares so as to elect
one (1) individual designated by the Investor, subject only to approval of the designated individual by AIM; and 

 

(e)          at
each election of directors in which the holders of Common Stock and holders of Preferred Stock, voting together as a single class
on an as-converted basis, are entitled to elect directors of the Company, for so long as a Key Shareholder
continues to hold shares of Common Stock and/or Preferred Stock of the Company entitling such Key Shareholder to ten percent (10%)
or more of the voting rights with respect to the Company, the Investor shall vote all of its Shares comprised of Common
Stock so as to elect one (1) individual designated by such Key Shareholder, subject only to approval
of the designated individual by AIM.

 

For purposes of this
Agreement, any individual, entity, or group or class of individuals and/or entities who has or have the right to designate a director
for election to the Company’s Board of Directors pursuant to the provisions of this Section 4 is hereinafter referred to
as a “Designator” or as “Designators” or, when referring to one or more Designators, “Designator(s)”
as applicable, and any such designee shall hereinafter be referred to as a “Designee.”

 

The Key Shareholder
and the Investor both separately agree that they will each not exercise their voting rights with respect to any Shares held by
them, and that they each shall use best efforts to ensure that any of their respective Related Parties will not exercise any of
the voting rights of such Related Parties with respect to the Shares held by them, for the purposes of (i) calling any meeting
of the shareholders of the Company at which the removal of any Designee of the Key Shareholder or the Investor as a member of the
Board of Directors of the Company is to be voted upon, without the prior written consent of the Party whose Designee is the subject
of removal from the Board of Directors, (ii) voting in favor of the removal of any Designee of the Key Shareholder or the Investor
as a member of the Board of Directors of the Company at any meeting of the Shareholders of the Company at which the removal of
any Designee of the Key Shareholder or the Investor as a member of the Board of Directors of the Company is to be voted upon, without
the prior written consent of the Party whose Designee is the subject of removal from the Board of Directors, or (iii) otherwise
approving any written consent of the shareholders of the Company seeking to remove any Designee of the Key Shareholder or the Investor
as a member of the Board of Directors of the Company, without the prior written consent of the Party whose Designee is the subject
of removal from the Board of Directors.

 

    	3

    	 

    

 

The Parties further agree
that within three (3) business days of the date of this Agreement, the Company and the Key Shareholder
shall take any and all necessary actions to elect Gavin Moran as the Investor’s initial Designee on the Company’s Board
of Directors.

 

5.            Changes
in Designees. From time to time during the term of this Agreement, Designator(s) may, in their sole discretion:

 

(a)          elect
to initiate a removal from the Company’s Board of Directors any incumbent Designee who occupies a Board seat for which such
Designator(s) are entitled to designate the Designee under Section 4; and/or

 

(b)          designate
a new Designee for election to a Board seat for which such Designator(s) are entitled to designate the Designee (whether to replace
a prior Designee or to fill a vacancy in such Board seat);

 

provided such removal
and/or designation of a Designee is approved in writing signed by the Designator or Designators entitled to designate such Designee
under Section 4, in which case such election to remove Designee and/or elect a new Designee will be binding on the Key Shareholder
or the Investor, as applicable. In the event of such an initiation of a removal or designation of a Designee under this Section
5, the Key Shareholder or the Investor, as the case may be, shall vote their respective Shares, as applicable, to cause: (i) the
removal from the Company’s Board of Directors of the Designee or Designees so designated for removal; and (ii) the election
to the Company’s Board Directors of any new Designee or Designees so designated for election to the Company’s Board
of Directors by the appropriate Designator or Designators. The Company shall take such reasonable actions as are necessary to facilitate
such removals or elections, including, without limitation, including the Designee in each slate of nominees proposed to the shareholders
of the Company and recommending his or her election to the Board of Directors and soliciting the votes of the appropriate Key Shareholder
and the Investor, and the Key Shareholder and the Investor shall vote all of their respective Shares entitled to vote at such meeting
or in connection with such consent in favor of such removals or elections. Any vote taken to remove any Designee elected pursuant
to Section 4, or to fill any vacancy created by the resignation, removal or death of a Designee elected pursuant to Section 4,
shall be subject to the provisions of this Agreement, including without limitation Section 4 and this Section 5.

 

    	4

    	 

    

 

6.          Additional
Changes to Organizational Documents. The Key Shareholder shall vote at a regular or special meeting of stockholders (or by
written consent) all of the Shares held by the Key Shareholder, and the Company and the Key Shareholder shall otherwise take all
actions necessary to ensure that at all times up to the time which is immediately prior to the issuance of capital stock of the
Company in connection with its first offering of Common Stock pursuant to an effective registration statement under the Securities
Act of 1933, as amended, the unanimous approval of the Board of Directors of the Company shall be required for any issuance by
the Company of any new shares of capital stock of the Company or any instruments convertible into shares of capital stock of the
Company (including any such issuance of shares of capital stock of the Company in connection with its first offering of Common
Stock of the Company pursuant to an effective registration statement under the Securities Act of 1933, as amended), including without
limitation voting in favor of any amendment to the Certificate of Incorporation or Bylaws of the Company that may be necessary
in order to effectively implement the requirements of this Section 6; provided, however, that the Parties acknowledge and agree
that the termination of the above requirements as of immediately prior to the issuance of capital stock of the Company in connection
with its first offering of Common Stock pursuant to an effective registration statement under the Securities Act of 1933, as amended,
shall not occur until after the Board of Directors of the Company has already granted final approval of such first offering of
Common Stock and the issuance of shares of Common Stock in connection therewith. The Key Shareholder shall vote at a regular or
special meeting of stockholders (or by written consent) all of the Shares held by the Key Shareholder, and the Company and the
Key Shareholder shall otherwise take all actions necessary, at all times up to the time which is immediately prior to the issuance
of capital stock of the Company in connection with its first offering of Common Stock pursuant to an effective registration statement
under the Securities Act of 1933, as amended, to ensure that any change or amendment to the organizational documents of the Company
providing for the removal of the requirements in the immediately preceding sentence shall require either (i) the unanimous approval
of the members of the Board of Directors or (ii) approval of the holders of at least a majority of the outstanding shares of capital
stock of the Company; provided, however, that the Parties acknowledge and agree that the termination of the above requirements
as of immediately prior to the issuance of capital stock of the Company in connection with its first offering of Common Stock pursuant
to an effective registration statement under the Securities Act of 1933, as amended, shall not occur until after the Board of Directors
of the Company has already granted final approval of such first offering of Common Stock and the issuance of shares of Common Stock
in connection therewith. The Key Shareholder further agrees that the Key Shareholder shall not vote at any regular or special meeting
of stockholders (or by written consent) in favor of any amendment or change to any of the organizational documents of the Company
that seeks to remove any of the requirements of this Section 6. The Company and the Key Shareholder further agree to take any and
all other actions that may be necessary under applicable law in order to implement the requirements of this Section 6, including
without limitation calling any special meetings of the shareholders and/or Board of Directors and/or entering into written consents
of the shareholders and/or Board of Directors as necessary under applicable law in order to effectively implement the requirements
of this Section 6. The Company and the Key Shareholder warrant and agree that the requirements set forth above in this Section
6 shall be implemented as soon as reasonably and practically possible following the Company’s next AGM, provided, however,
that the requirements set forth above in this Section 3 shall be implemented by no later than thirty (30) calendar days following
such AGM.

 

    	5

    	 

    

 

7.           Additional
Covenants. The Key Shareholder agrees that he shall not vote in any capacity in favor of any amendment to the Certificate of
Incorporation, Bylaws or any organizational document of the Company that seeks to remove, amend, or in any way alter the voting
agreements of the Parties set forth in this Agreement or any of the other rights of the Investor set forth in this Agreement. The
Investor agrees that the Investor shall not vote in any capacity in favor of any amendment to the Certificate of Incorporation,
Bylaws or any organizational document of the Company that seeks to remove, amend, or in any way alter the voting agreements of
the Parties set forth in this Agreement or any of the other rights of the Key Shareholder set forth in this Agreement.

 

8.           Covenants
of the Company.

 

(a)          The
Company will not, by any voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be performed
hereunder by the Company, but will at all times in good faith assist in the carrying out of all of the provisions of this Agreement
and in the taking of all such actions as may be necessary, appropriate or reasonably requested by the Investor in order to protect
the rights of the Parties hereunder against impairment.

 

(b)          Following
the date of this Agreement, until consummation of all transactions contemplated hereby, the Company shall give to the Investor,
its counsel, financial advisers, auditors and other authorized representatives reasonable access to the offices, properties, books
and records, financial and other data and information as the Investor and its representatives may reasonably request.

 

(c)          The
Company warrants that it has no current intention to issue any new shares of capital stock of the Company to the Key Shareholder
or any third party until the requirements of Sections 3 through 6 of this Agreement have been fully implemented in accordance with
their terms.

 

9.           No
Liability for Election of Recommended Directors. Neither the Investor nor any officer, director, stockholder, partner, employee
or agent of the Investor, makes any representation or warranty as to the fitness or competence of any Designee of the Investor
to serve on the Company’s Board, whether designated under this Agreement or designated at any time in the future under the
terms of this Agreement.

 

10.         Grant
of Proxies. Upon the failure of the Key Shareholder to vote the Key Shareholder Shares in accordance with the terms of this
Agreement, the Key Shareholder hereby grants to the Investor a proxy coupled with an interest in all Key Shareholder Shares owned
by the Key Shareholder, which proxy in each case shall be irrevocable until this Agreement terminates pursuant to its terms, to
vote all the Key Shareholder Shares in the manner provided in Sections 3, 4, 5 and 6 hereof. Upon the failure of the Investor to
vote the Investor’s Investor Shares in accordance with the terms of this Agreement, the Investor hereby grants to the Key
Shareholder a proxy coupled with an interest in all Investor Shares owned by the Investor, which proxy in each case shall be irrevocable
until this Agreement terminates pursuant to its terms, to vote all such Investor Shares in the manner provided in Sections 3, 4
and 6 hereof.

 

11.         Specific
Enforcement. It is agreed and understood that monetary damages would not adequately compensate an injured Party for the breach
of this Agreement by any other Party, that this Agreement shall be specifically enforceable, and that any breach or threatened
breach of this Agreement shall be the proper subject of a temporary or permanent injunction or restraining order. Further, each
Party waives any claim or defense that there is an adequate remedy at law for such breach or threatened breach.

 

    	6

    	 

    

 

 

12.         Execution
by the Company. The Company, by its execution in the space provided below, agrees that it shall supply, free of charge, a copy
of this Agreement to any holder of a certificate evidencing shares of capital stock of the Company upon written request from such
holder to the Company at its principal office.

 

13.         Captions.
The captions, headings and arrangements used in this Agreement are for convenience only and do not in any way limit or amplify
the terms and provisions hereof.

 

14.         Notices.
All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively
given (a) upon personal delivery to the party to be notified, (b) when sent by facsimile if sent during normal business hours of
the recipient, and if not so confirmed, then on the next business day, or (c) one (1) day after deposit with a nationally recognized
overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the
respective Parties at their address as set forth in the opening paragraph of this Agreement. If notice is given to the Investor,
a copy shall also be sent to Giordano, Halleran & Ciesla, P.C., 125 Half Mile Road, Red Bank, New Jersey 07701, Attention:
Patrick S. Convery, Esq.

 

15.         Term.
This Agreement shall terminate and be of no further force or effect immediately prior to the consummation of Company’s first
offering of its Common Stock pursuant to an effective registration statement under the Securities Act of 1933, as amended; provided,
however, that the Parties acknowledge and agree that the termination of this Agreement as of immediately prior to the issuance
of capital stock of the Company in connection with its first offering of Common Stock pursuant to an effective registration statement
under the Securities Act of 1933, as amended, shall not occur until after the Board of Directors of the Company has already granted
final approval of such first offering of Common Stock and the issuance of shares of Common Stock in connection therewith.

 

16.         Manner
of Voting. The voting of shares pursuant to this Agreement may be effected in person, by proxy, by written consent or in any
other manner permitted by applicable law.

 

17.         Amendments
and Waivers. Any term hereof may be amended and the observance of any term hereof may be waived (either generally or in a particular
instance and either retroactively or prospectively) only with the written consent of (i) the Company (ii) the Key Shareholder,
and (iii) the Investor.

 

18.         Stock
Splits, Stock Dividends, etc. In the event of any issuance of shares of the Company’s voting securities hereafter to
any of the Parties (including, without limitation, in connection with any stock split, stock dividend, recapitalization, reorganization
or the like), such shares shall become subject to this Agreement.

 

19.         Severability.
Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Agreement shall be held to be prohibited by or invalid under applicable law, such provision shall
be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of such provision or the
remaining provisions of this Agreement.

 

    	7

    	 

    

 

20.         Successors
and Assigns. The provisions hereof shall inure to the benefit of, and be binding upon, the Parties and their respective successors,
assigns, heirs, executors and administrators and other legal representatives.

 

21.         Aggregation
of Stock. All shares of capital stock of the Company (and warrants and rights to purchase the same) that are held or acquired
by persons or entities that are affiliates of one another or that are under common investment management shall be aggregated together
for the purpose of exercising or determining the availability of any rights under this Agreement.

 

22.         Binding
Effect. In addition to any restriction on transfer that may be imposed by any other agreement by which any Party may be bound,
this Agreement shall be binding upon the Parties, their respective heirs, successors, and Related Party transferees and assigns
that may become stockholders of the Company by virtue of the transfer of any Shares; provided that for any such transfer to be
deemed effective, the transferee shall have executed and delivered an Adoption Agreement substantially in the form attached hereto
as Exhibit A. Upon the execution and delivery of an Adoption Agreement by a transferee reasonably acceptable to the Company,
such transferee shall be deemed to be a party to this Agreement as if such transferee’s signature appeared on the signature
page of this Agreement. By its execution hereof or any Adoption Agreement, each of the Parties appoints the Company as its attorney-in-fact
for the purpose of executing any Adoption Agreement which may be required to be delivered hereunder.

 

23.         Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New Jersey, without regard
to conflicts of law principles thereof. 

 

24.         Entire
Agreement. This Agreement is intended to be the sole agreement of the Parties as it relates to the subject matter hereof and
supersedes all other agreements of the Parties relating to the subject matter hereof.

 

25.         Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same instrument.

 

[SIGNATURE PAGE FOLLOWS]

 

    	8

    	 

    

 

IN WITNESS WHEREOF, the Parties have
caused this Agreement to be executed on and as of the date set forth above.

 

	 	AKERS BIOSCIENCES, INC.,
	 	a New Jersey corporation
	 	 
	 	By: 	 
	 	Name:
	 	Title:
	 	 
	 	By: 	 
	 	Thomas J. Knox
	 	 
	 	CHUBEWORKX GUERNSEY

LIMITED,
	 	a company incorporated in Guernsey
	 	 
	 	By: 	 
	 	Name:
	 	Title:

 

    	 

    	 

    

 

EXHIBIT A

 

ADOPTION AGREEMENT

 

This Adoption Agreement
(“Adoption Agreement”) is executed by the undersigned (the “Transferee”) pursuant to the terms of that
certain Voting Agreement dated as of June 12, 2013 (the “Agreement”) by and among the Company and certain of its stockholders.
Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Agreement. By the
execution of this Adoption Agreement, the Transferee agrees as follows:

 

Acknowledgment.
Transferee acknowledges that Transferee is acquiring certain shares of the capital stock of the Company (the “Stock”),
subject to the terms and conditions of the Agreement.

 

Agreement.
Transferee (i) agrees that the Stock acquired by Transferee shall be bound by and subject to the terms of the Agreement, and
(ii) hereby adopts the Agreement with the same force and effect as if Transferee were originally a party thereto. 

 

Notice.
Any notice required or permitted by the Agreement shall be given to Transferee at the
address listed beside Transferee’s signature below.

 

EXECUTED AND DATED
this ______ day of _________________, 20__.

 

	 	TRANSFEREE:
	 	 
	 	By:  	 
	 	 	Name and Title
	 	 	 
	 	Address:  	 
	 	Fax:  	 

 

Accepted and Agreed:

 

	AKERS BIOSCIENCES, INC.,	 
	a New Jersey corporation	 
	 	 
	By: 	 	 
	Name:  	 
	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00220-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00220-of-00352.parquet"}]]